| Mary Rita Mccotter Desi, MD | |
|
16312 Mount Airy Rd, Shrewsbury, PA 17361-1623 | |
| (717) 227-3800 | |
| (717) 227-3802 |
| Full Name | Mary Rita Mccotter Desi |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 16312 Mount Airy Rd, Shrewsbury, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255659074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD449160 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
By not implementing a neuroblastoma screening program between 1989 and 2002, the United States and Canada saved $574.1 million in health costs, avoided the unnecessary treatment of more than 9,200 children, and avoided false-positive findings in more than 5,000 children, according to a new study in the August 3 issue of the Journal of the National Cancer Institute.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
A University of Michigan Health System study provides new clues about the health-damaging molecular changes set in motion by eating high-fat foods.
As governors took to Capitol Hill this week to talk about their state budgets, Medicaid and the implementation of the health law, more attention was focused on the issues and cost estimates involved in the debate.
› Verified 5 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326060492 PECOS PAC ID: 2961307467 Enrollment ID: O20031205000629 |
News Archive
By not implementing a neuroblastoma screening program between 1989 and 2002, the United States and Canada saved $574.1 million in health costs, avoided the unnecessary treatment of more than 9,200 children, and avoided false-positive findings in more than 5,000 children, according to a new study in the August 3 issue of the Journal of the National Cancer Institute.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
A University of Michigan Health System study provides new clues about the health-damaging molecular changes set in motion by eating high-fat foods.
As governors took to Capitol Hill this week to talk about their state budgets, Medicaid and the implementation of the health law, more attention was focused on the issues and cost estimates involved in the debate.
› Verified 5 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
By not implementing a neuroblastoma screening program between 1989 and 2002, the United States and Canada saved $574.1 million in health costs, avoided the unnecessary treatment of more than 9,200 children, and avoided false-positive findings in more than 5,000 children, according to a new study in the August 3 issue of the Journal of the National Cancer Institute.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
A University of Michigan Health System study provides new clues about the health-damaging molecular changes set in motion by eating high-fat foods.
As governors took to Capitol Hill this week to talk about their state budgets, Medicaid and the implementation of the health law, more attention was focused on the issues and cost estimates involved in the debate.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Rita Mccotter Desi, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-2521 | Mary Rita Mccotter Desi, MD 16312 Mount Airy Rd, Shrewsbury, PA 17361-1623 Ph: (717) 227-3800 |
News Archive
By not implementing a neuroblastoma screening program between 1989 and 2002, the United States and Canada saved $574.1 million in health costs, avoided the unnecessary treatment of more than 9,200 children, and avoided false-positive findings in more than 5,000 children, according to a new study in the August 3 issue of the Journal of the National Cancer Institute.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it received a complaint filed by Celgene Corporation seeking a declaration from the court that four Cyclacel-owned patents, which claim the use of romidepsin injection in T-cell lymphomas, are not infringed by Celgene's products and are invalid.
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
A University of Michigan Health System study provides new clues about the health-damaging molecular changes set in motion by eating high-fat foods.
As governors took to Capitol Hill this week to talk about their state budgets, Medicaid and the implementation of the health law, more attention was focused on the issues and cost estimates involved in the debate.
› Verified 5 days ago
Dr. Adedamola Adetola Falokun, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 96 Sofia Dr Ste 208, Shrewsbury, PA 17361 Phone: 717-812-2400 Fax: 717-812-3005 | |
Nandita Tandon Kinley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16312 Mount Airy Rd, Shrewsbury, PA 17361 Phone: 717-227-3800 Fax: 717-227-3802 | |
Amy Beth Pedone, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16312 Mount Airy Rd, Shrewsbury, PA 17361 Phone: 717-227-3800 | |
Dr. Jessica Sarah Starner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 16312 Mount Airy Rd, Shrewsbury, PA 17361 Phone: 717-227-3800 | |
Dr. Marcia Susan Miller Mccarty, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 278 Prospect Cir, Shrewsbury, PA 17361 Phone: 717-227-1619 | |
Dr. Ann Carder Miller, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Old Farm Ln, Shrewsbury, PA 17361 Phone: 717-235-4893 Fax: 717-227-0811 |